A new radiobiology-based HDR brachytherapy treatment planning algorithm used to investigate the potential for hypofractionation in cervical cancer

Kaelyn Seeley,I-Chow J. Hsu,Tae Min Hong,J. Adam Cunha

DOI: https://doi.org/10.48550/arXiv.1712.00101

2017-12-01

Abstract:Most commercially available treatment planning systems for brachytherapy operate based on physical dose and do not incorporate fractionation or tissue-specific response. The purpose of this study is to investigate the potential for hypofractionation in HDR brachytherapy, thereby reducing the number of implants required. A new treatment planning algorithm was built in order to optimize based on tissue and fractionation specific parameters. Different fractionation schemes were considered for 6 patients, and plans were created using the new algorithm. A baseline fractionation scheme consisting of 5 fractions was compared to hypofractionated plans of 1 to 4 fractions. The effectiveness of each plan was evaluated using radiobiological criteria taken from GEC-ESTRO guidelines. The results of this study indicate that an optimization algorithm based on biological parameters has similar functionality to traditional planning methods with the additional ability to account for fractionation effects. Using this algorithm, it was shown that plans consisting of 3 and 4 fractions have comparable target coverage with equivalent normal tissue exposure. In some specific cases, further fractionation may present acceptable target coverage as well.

Medical Physics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **To explore the feasibility of reducing the number of fractions (i.e., hypofractionation) in high - dose - rate (HDR) brachytherapy for cervical cancer, in order to reduce the required number of implantations while ensuring that tumor target area coverage and normal tissue toxicity are within an acceptable range.**

Specifically, most current commercial treatment planning systems are optimized based on physical doses and do not consider fractionation effects or tissue - specific responses. Therefore, the research aims to develop a new treatment planning algorithm based on radiobiological parameters to evaluate the potential advantages of hypofractionation regimens in HDR brachytherapy for cervical cancer.

### Research Background

1. **Limitations of Traditional Methods**
- Current HDR brachytherapy usually requires 5 or more fractions and lasts for several weeks.
- Commercial treatment planning systems are mainly optimized based on physical doses and do not consider fractionation effects or tissue - specific responses.

2. **Potential Advantages of Hypofractionation**
- Reducing the number of fractions can improve patient comfort and reduce economic burden.
- By reducing the number of fractions, the number of patient trips to the hospital can be reduced, thereby improving the convenience and compliance of treatment.

3. **Application of Radiobiological Models**
- The α/β ratio of cervical cancer tissue is relatively high (about 10 Gy), which belongs to "early - response" tissue and is more sensitive to hypofractionated high - dose treatment.
- Using radiobiological models (such as biological effective dose BED and equivalent 2 Gy fraction dose EQD2) can help better evaluate the effects of different fractionation regimens.

### Research Objectives

- **Develop a New Treatment Planning Algorithm**: Optimize the treatment plan based on radiobiological parameters, considering fractionation effects and tissue - specific responses.
- **Evaluate the Feasibility of Hypofractionation Regimens**: By comparing the efficacy of different fractionation regimens (1 to 4 fractions) with the standard 5 - fraction regimen, evaluate whether the hypofractionation regimens can control normal tissue toxicity while ensuring tumor target area coverage.

### Methods and Materials

1. **Patient Data**: Select the imaging data of 6 cervical cancer patients for the study.
2. **Optimization Algorithm**: Develop an optimization algorithm based on radiobiological parameters, and use the IPSA (Inverse Planning by Simulated Annealing) framework for improvement.
3. **Evaluation Indicators**: Use radiobiological dosimetry standards (such as GEC - ESTRO guidelines) to evaluate the effects of different fractionation regimens, with a focus on target area coverage and normal tissue toxicity.

### Results

- **3 - and 4 - Fraction Regimens**: In some cases, 3 - and 4 - fraction regimens can provide target area coverage comparable to that of the standard 5 - fraction regimen, and the normal tissue exposure is comparable.
- **Potential of Hypofractionation Regimens**: Although 1 - or 2 - fraction regimens are not feasible in most cases, 3 - and 4 - fraction regimens are clinically feasible and can maintain the treatment effect while reducing the number of implantations.

### Conclusions

The optimization algorithm based on radiobiological parameters has clinically acceptable performance. The treatment plans generated by this algorithm show that, under appropriate circumstances, reducing the number of fractions (such as 3 or 4) is feasible and can reduce the patient's burden while ensuring the treatment effect.